A股異動 | 華中數控(300161.SZ)急升至漲停 2019年預盈1420萬元至1920萬元
格隆匯2月3日丨華中數控(300161.SZ)午後開盤後直線拉昇至漲停,大幅震盪近19%。現報16.91元,暫成交1.75億元,最新總市值29.21億元。華中數控(300161.SZ)2019年預盈1420萬元至1920萬元,同比變動-14.88%至15.09%。公司積極開拓市場,銷售收入實現同比增長,同時研發費用較上年同期增加,公司歸屬於上市公司股東的淨利潤與上年同期基本持平。公司近日收到項目經費855.53萬元。本次收到的項目經費對公司2020年的利潤影響金額為572.04萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.